Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma. 2011

Nicholas Butowski, and Susan M Chang, and Kathleen R Lamborn, and Mei-Yin Polley, and Russell Pieper, and Joseph F Costello, and Scott Vandenberg, and Rupa Parvataneni, and Angelina Nicole, and Patricia K Sneed, and Jennifer Clarke, and Emily Hsieh, and Bruno M Costa, and Rui M Reis, and Maria Hristova-Kazmierski, and Steven J Nicol, and Donald E Thornton, and Michael D Prados
Neuro-Oncology Service, Department of Neurological Surgery, University of California, San Francisco, 400 Parnassus Avenue, A808, San Francisco, CA 94143-0350, USA. butowski@neurosurg.ucsf.edu

This open-label, single-arm, phase II study combined enzastaurin with temozolomide plus radiation therapy (RT) to treat glioblastoma multiforme (GBM) and gliosarcoma. Adults with newly diagnosed disease and Karnofsky performance status (KPS) ≥ 60 were enrolled. Treatment was started within 5 weeks after surgical diagnosis. RT consisted of 60 Gy over 6 weeks. Temozolomide was given at 75 mg/m(2) daily during RT and then adjuvantly at 200 mg/m(2) daily for 5 days, followed by a 23-day break. Enzastaurin was given once daily during RT and in the adjuvant period at 250 mg/day. Cycles were 28 days. The primary end point was overall survival (OS). Progression-free survival (PFS), toxicity, and correlations between efficacy and molecular markers analyzed from tumor tissue samples were also evaluated. A prospectively planned analysis compared OS and PFS of the current trial with outcomes from 3 historical phase II trials that combined novel agents with temozolomide plus RT in patients with GBM or gliosarcoma. Sixty-six patients were enrolled. The treatment regimen was well tolerated. OS (median, 74 weeks) and PFS (median, 36 weeks) results from the current trial were comparable to those from a prior phase II study using erlotinib and were significantly better than those from 2 other previous studies that used thalidomide or cis-retinoic acid, all in combination with temozolomide plus RT. A positive correlation between O-6-methylguanine-DNA methyltransferase promoter methylation and OS was observed. Adjusting for age and KPS, no other biomarker was associated with survival outcome. Correlation of relevant biomarkers with OS may be useful in future trials.

UI MeSH Term Description Entries
D007124 Immunoenzyme Techniques Immunologic techniques based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens. Antibody Enzyme Technique, Unlabeled,Enzyme Immunoassay,Enzyme-Labeled Antibody Technique,Immunoassay, Enzyme,Immunoperoxidase Techniques,Peroxidase-Antiperoxidase Complex Technique,Peroxidase-Labeled Antibody Technique,Antibody Enzyme Technic, Unlabeled,Enzyme-Labeled Antibody Technic,Immunoenzyme Technics,Immunoperoxidase Technics,Peroxidase-Antiperoxidase Complex Technic,Peroxidase-Labeled Antibody Technic,Antibody Technic, Enzyme-Labeled,Antibody Technic, Peroxidase-Labeled,Antibody Technics, Enzyme-Labeled,Antibody Technics, Peroxidase-Labeled,Antibody Technique, Enzyme-Labeled,Antibody Technique, Peroxidase-Labeled,Antibody Techniques, Enzyme-Labeled,Antibody Techniques, Peroxidase-Labeled,Enzyme Immunoassays,Enzyme Labeled Antibody Technic,Enzyme Labeled Antibody Technique,Enzyme-Labeled Antibody Technics,Enzyme-Labeled Antibody Techniques,Immunoassays, Enzyme,Immunoenzyme Technic,Immunoenzyme Technique,Immunoperoxidase Technic,Immunoperoxidase Technique,Peroxidase Antiperoxidase Complex Technic,Peroxidase Antiperoxidase Complex Technique,Peroxidase Labeled Antibody Technic,Peroxidase Labeled Antibody Technique,Peroxidase-Antiperoxidase Complex Technics,Peroxidase-Antiperoxidase Complex Techniques,Peroxidase-Labeled Antibody Technics,Peroxidase-Labeled Antibody Techniques,Technic, Enzyme-Labeled Antibody,Technic, Immunoenzyme,Technic, Immunoperoxidase,Technic, Peroxidase-Antiperoxidase Complex,Technic, Peroxidase-Labeled Antibody,Technics, Enzyme-Labeled Antibody,Technics, Immunoenzyme,Technics, Immunoperoxidase,Technics, Peroxidase-Antiperoxidase Complex,Technics, Peroxidase-Labeled Antibody,Technique, Enzyme-Labeled Antibody,Technique, Immunoenzyme,Technique, Immunoperoxidase,Technique, Peroxidase-Antiperoxidase Complex,Technique, Peroxidase-Labeled Antibody,Techniques, Enzyme-Labeled Antibody,Techniques, Immunoenzyme,Techniques, Immunoperoxidase,Techniques, Peroxidase-Antiperoxidase Complex,Techniques, Peroxidase-Labeled Antibody
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D010597 Pharmacogenetics A branch of genetics which deals with the genetic variability in individual responses to drugs and drug metabolism (BIOTRANSFORMATION). Pharmacogenomics
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D003606 Dacarbazine An antineoplastic agent. It has significant activity against melanomas. (from Martindale, The Extra Pharmacopoeia, 31st ed, p564) DTIC,5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide,Biocarbazine,DIC,DTIC-Dome,Decarbazine,Deticene,Dimethyl Imidazole Carboxamide,Dimethyl Triazeno Imidazole Carboxamide,ICDT,NSC-45388,Carboxamide, Dimethyl Imidazole,DTIC Dome,DTICDome,Imidazole Carboxamide, Dimethyl,NSC 45388,NSC45388

Related Publications

Nicholas Butowski, and Susan M Chang, and Kathleen R Lamborn, and Mei-Yin Polley, and Russell Pieper, and Joseph F Costello, and Scott Vandenberg, and Rupa Parvataneni, and Angelina Nicole, and Patricia K Sneed, and Jennifer Clarke, and Emily Hsieh, and Bruno M Costa, and Rui M Reis, and Maria Hristova-Kazmierski, and Steven J Nicol, and Donald E Thornton, and Michael D Prados
January 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Nicholas Butowski, and Susan M Chang, and Kathleen R Lamborn, and Mei-Yin Polley, and Russell Pieper, and Joseph F Costello, and Scott Vandenberg, and Rupa Parvataneni, and Angelina Nicole, and Patricia K Sneed, and Jennifer Clarke, and Emily Hsieh, and Bruno M Costa, and Rui M Reis, and Maria Hristova-Kazmierski, and Steven J Nicol, and Donald E Thornton, and Michael D Prados
October 2004, International journal of radiation oncology, biology, physics,
Nicholas Butowski, and Susan M Chang, and Kathleen R Lamborn, and Mei-Yin Polley, and Russell Pieper, and Joseph F Costello, and Scott Vandenberg, and Rupa Parvataneni, and Angelina Nicole, and Patricia K Sneed, and Jennifer Clarke, and Emily Hsieh, and Bruno M Costa, and Rui M Reis, and Maria Hristova-Kazmierski, and Steven J Nicol, and Donald E Thornton, and Michael D Prados
May 2010, Journal of neuro-oncology,
Nicholas Butowski, and Susan M Chang, and Kathleen R Lamborn, and Mei-Yin Polley, and Russell Pieper, and Joseph F Costello, and Scott Vandenberg, and Rupa Parvataneni, and Angelina Nicole, and Patricia K Sneed, and Jennifer Clarke, and Emily Hsieh, and Bruno M Costa, and Rui M Reis, and Maria Hristova-Kazmierski, and Steven J Nicol, and Donald E Thornton, and Michael D Prados
November 2012, International journal of radiation oncology, biology, physics,
Nicholas Butowski, and Susan M Chang, and Kathleen R Lamborn, and Mei-Yin Polley, and Russell Pieper, and Joseph F Costello, and Scott Vandenberg, and Rupa Parvataneni, and Angelina Nicole, and Patricia K Sneed, and Jennifer Clarke, and Emily Hsieh, and Bruno M Costa, and Rui M Reis, and Maria Hristova-Kazmierski, and Steven J Nicol, and Donald E Thornton, and Michael D Prados
March 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Nicholas Butowski, and Susan M Chang, and Kathleen R Lamborn, and Mei-Yin Polley, and Russell Pieper, and Joseph F Costello, and Scott Vandenberg, and Rupa Parvataneni, and Angelina Nicole, and Patricia K Sneed, and Jennifer Clarke, and Emily Hsieh, and Bruno M Costa, and Rui M Reis, and Maria Hristova-Kazmierski, and Steven J Nicol, and Donald E Thornton, and Michael D Prados
August 2014, Autophagy,
Nicholas Butowski, and Susan M Chang, and Kathleen R Lamborn, and Mei-Yin Polley, and Russell Pieper, and Joseph F Costello, and Scott Vandenberg, and Rupa Parvataneni, and Angelina Nicole, and Patricia K Sneed, and Jennifer Clarke, and Emily Hsieh, and Bruno M Costa, and Rui M Reis, and Maria Hristova-Kazmierski, and Steven J Nicol, and Donald E Thornton, and Michael D Prados
April 2011, Advances in therapy,
Nicholas Butowski, and Susan M Chang, and Kathleen R Lamborn, and Mei-Yin Polley, and Russell Pieper, and Joseph F Costello, and Scott Vandenberg, and Rupa Parvataneni, and Angelina Nicole, and Patricia K Sneed, and Jennifer Clarke, and Emily Hsieh, and Bruno M Costa, and Rui M Reis, and Maria Hristova-Kazmierski, and Steven J Nicol, and Donald E Thornton, and Michael D Prados
April 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Nicholas Butowski, and Susan M Chang, and Kathleen R Lamborn, and Mei-Yin Polley, and Russell Pieper, and Joseph F Costello, and Scott Vandenberg, and Rupa Parvataneni, and Angelina Nicole, and Patricia K Sneed, and Jennifer Clarke, and Emily Hsieh, and Bruno M Costa, and Rui M Reis, and Maria Hristova-Kazmierski, and Steven J Nicol, and Donald E Thornton, and Michael D Prados
December 2009, Journal of neuro-oncology,
Nicholas Butowski, and Susan M Chang, and Kathleen R Lamborn, and Mei-Yin Polley, and Russell Pieper, and Joseph F Costello, and Scott Vandenberg, and Rupa Parvataneni, and Angelina Nicole, and Patricia K Sneed, and Jennifer Clarke, and Emily Hsieh, and Bruno M Costa, and Rui M Reis, and Maria Hristova-Kazmierski, and Steven J Nicol, and Donald E Thornton, and Michael D Prados
December 2004, Cancer,
Copied contents to your clipboard!